| __timestamp | Pfizer Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 14097000000 | 612613000000 |
| Thursday, January 1, 2015 | 14809000000 | 650773000000 |
| Friday, January 1, 2016 | 14837000000 | 619061000000 |
| Sunday, January 1, 2017 | 14784000000 | 628106000000 |
| Monday, January 1, 2018 | 14455000000 | 717599000000 |
| Tuesday, January 1, 2019 | 14350000000 | 964737000000 |
| Wednesday, January 1, 2020 | 11615000000 | 875663000000 |
| Friday, January 1, 2021 | 12703000000 | 886361000000 |
| Saturday, January 1, 2022 | 13677000000 | 997309000000 |
| Sunday, January 1, 2023 | 14771000000 | 1053819000000 |
| Monday, January 1, 2024 | 14730000000 | 1053819000000 |
Unveiling the hidden dimensions of data
In the ever-evolving pharmaceutical industry, operational efficiency is key to maintaining a competitive edge. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two industry giants, Pfizer Inc. and Takeda Pharmaceutical Company Limited, from 2014 to 2023. Over this period, Pfizer's SG&A expenses remained relatively stable, averaging around $14 billion annually. In contrast, Takeda's expenses surged by approximately 72%, from $612 billion in 2014 to over $1 trillion in 2023. This stark difference highlights Takeda's aggressive expansion strategy, possibly driven by acquisitions and market penetration efforts. Notably, 2020 marked a dip in Pfizer's expenses, coinciding with global economic shifts. Missing data for Pfizer in 2024 suggests a need for further investigation. This comparative insight underscores the diverse strategic approaches within the pharmaceutical sector.
Comparing SG&A Expenses: Merck & Co., Inc. vs Takeda Pharmaceutical Company Limited Trends and Insights
Pfizer Inc. and Viatris Inc.: SG&A Spending Patterns Compared
Pfizer Inc. and Sarepta Therapeutics, Inc.: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Pfizer Inc. and Walgreens Boots Alliance, Inc.
Pfizer Inc. or BioCryst Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Takeda Pharmaceutical Company Limited
Breaking Down SG&A Expenses: Takeda Pharmaceutical Company Limited vs Viatris Inc.
Takeda Pharmaceutical Company Limited or Dr. Reddy's Laboratories Limited: Who Manages SG&A Costs Better?
Takeda Pharmaceutical Company Limited vs Apellis Pharmaceuticals, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Takeda Pharmaceutical Company Limited and Merus N.V.
Cost Management Insights: SG&A Expenses for Takeda Pharmaceutical Company Limited and Bausch Health Companies Inc.
SG&A Efficiency Analysis: Comparing Takeda Pharmaceutical Company Limited and Geron Corporation